If your pharmacy spend feels unpredictable year after year, this is how to finally take control, plan ahead, and walk into renewal season with confidence instead of uncertainty.
Table of Contents
- Why does this always feel like a surprise?
- Why pharmacy costs are so hard to predict
- What employers should be looking at before renewal
- The biggest mistake employers make and how to avoid it
- How to actually forecast pharmacy costs (step by step)
- Strategies to reduce uncertainty before renewal
- What a confident renewal season looks like
- From guessing to planning
- Key Takeaways
Why does this always feel like a surprise?
You sit down to review your healthcare budget, expecting the usual adjustments. Maybe a slight increase here, a small shift there.
But then you see it.
Pharmacy costs have jumped, not just a little, but enough to raise real concerns. And the first thought that comes to mind is the same one many employers have every year:
“We didn’t see this coming.”
If that sounds familiar, you’re not alone.
Employers across the country are facing the same challenge. Prescription drug costs continue to rise, often driven by factors that feel outside of your control. At the same time, there’s constant pressure to manage budgets responsibly while still offering competitive, meaningful benefits to employees.
Cutting benefits isn’t a realistic solution. Absorbing unpredictable cost increases year after year isn’t sustainable either. That’s where the frustration starts to build.
What makes this even more challenging is the lack of visibility. Pharmacy spend often shows up as a surprise instead of something you can anticipate and plan for.
But here’s the part most employers aren’t told:
Pharmacy costs don’t have to be unpredictable.
With the right data, better transparency, and a more structured approach, it’s possible to forecast pharmacy spend before renewal season and avoid those last-minute surprises.
And once you do, everything changes.
Why pharmacy costs are so hard to predict
If forecasting pharmacy costs has ever felt confusing or even impossible, there’s a reason for that.
Most employers are not given a clear and complete picture of what is actually driving their pharmacy spend. Without that level of visibility, even well-planned budgets can quickly become outdated.
One of the biggest challenges comes from specialty medications.
These drugs are often used to treat chronic or complex conditions and come with significantly higher price tags. When even one or two employees begin using these medications, overall pharmacy spend can increase faster than expected.
Another factor is limited transparency within traditional PBM models.
Pricing structures are often complex, and key details about how costs are calculated are not always easy to access. This makes it difficult to fully understand where money is going and why certain costs are increasing.
There is also the issue of delayed reporting and unclear data.
Many employers are reviewing pharmacy reports that reflect what has already happened, rather than what is happening now. Without real-time insights, there is very little opportunity to adjust strategy before renewal.
On top of that, hidden costs can quietly impact the total spend.
Rebates, spread pricing, and other behind-the-scenes mechanisms are not always visible in a straightforward way. As a result, pharmacy costs may appear stable during the year, only to shift significantly when renewal approaches.
When all of these elements are combined, forecasting becomes much more difficult than it should be.
Most employers are doing their best to plan ahead, but they are often working with incomplete and delayed information, which makes accurate forecasting a real challenge.
What employers should be looking at before renewal
If pharmacy costs have felt unpredictable in the past, the goal moving forward is simple: shift from reacting to costs to preparing for them. That shift starts by knowing exactly where to look.
Instead of waiting for renewal numbers to tell the story , employers can begin building a clearer picture in advance by reviewing a few key areas.
First, start with historical claims data, ideally from the past 12 to 24 months.
This helps establish a baseline and reveals patterns over time. Are costs steadily increasing? Were there sudden spikes? Looking at trends over a longer period gives much more context than a single snapshot.
Next, take a closer look at high-cost claimants and specialty drug usage.
A small number of members often account for a large portion of total pharmacy spend. Understanding which medications are driving those costs and whether they are ongoing or one-time cases can make a significant difference in forecasting.
It’s also important to evaluate utilization patterns.
What medications are being used more frequently? Are certain drug classes, like GLP-1s or specialty treatments, becoming more common within your population? Identifying what’s increasing helps anticipate where costs may continue to rise.
Another area many employers overlook is pipeline drugs.
New medications entering the market, especially in specialty categories, can have a major financial impact. Having visibility into what’s coming allows you to prepare instead of react after costs have already increased.
Finally, consider how plan design influences utilization.
Copay structures, access to certain medications, and overall benefit design all play a role in how employees use their pharmacy benefits. Small changes here can significantly affect total spend over time.
When these areas are reviewed together, forecasting becomes much more grounded and actionable.
You’re no longer relying on assumptions or waiting for surprises. You’re using real data to understand what’s happening now and what’s likely to happen next.
The biggest mistake employers make and how to avoid it
When it comes to pharmacy costs, one mistake shows up more often than any other.
Employers wait until renewal quotes arrive to take a closer look at their pharmacy spend.
At that point, the numbers are already set. The increases are already built in. And the conversation quickly shifts from strategy to damage control.
The challenge with this approach is timing.
By the time renewal is on the table, there is very little room to make meaningful changes. Adjusting plan design, implementing cost management strategies, or exploring alternative solutions all require time. Without that lead time, options become limited.
There is also less leverage in conversations with vendors.
When decisions need to be made quickly, it becomes harder to ask deeper questions, evaluate different approaches, or negotiate more favorable terms. Employers often end up choosing between a few predefined options rather than shaping a strategy that truly fits their needs.
This is how pharmacy benefits become reactive.
Decisions are made under pressure, with incomplete information, and with a focus on short-term adjustments instead of long-term control.
A more effective approach starts earlier.
Forecasting should happen well before renewal is in sight. When employers begin reviewing data, identifying trends, and exploring strategies in advance, they gain time, flexibility, and a clearer understanding of their options.
Preparation changes the entire dynamic.
Instead of reacting to rising costs, employers are in a position to anticipate them, plan for them, and make more confident decisions when renewal season arrives.
How to actually forecast pharmacy costs (Step-by-step)
Forecasting pharmacy costs might sound complex, but it doesn’t have to be.
You don’t need to be an actuary or have a background in analytics. What matters is having a structured approach and knowing which data points to focus on.
Here’s how to break it down step by step:
Step 1: Analyze current spend
Start by understanding where your pharmacy dollars are going today.
Look at your data and break it down into clear categories:
- Specialty vs. traditional medications
- Top therapeutic classes driving spend
- High-cost members and prescriptions
This step gives you a baseline. Without it, everything else becomes guesswork.
Step 2: Identify cost drivers
Once you understand your current spend, the next step is identifying what’s pushing costs higher.
Pay close attention to:
- GLP-1 medications and specialty drugs
- Chronic conditions that require ongoing treatment
- Trends that are increasing year over year
Some cost drivers are already visible. Others are emerging quickly. Recognizing both helps you stay ahead instead of reacting later.
Step 3: Project future utilization
Now take a step forward and ask: What happens if current trends continue?
Look at your population and consider:
- Workforce demographics
- Adoption of high-cost medications
- Ongoing treatments that are likely to continue
This is where forecasting becomes more strategic. You’re not just looking at what happened, you’re estimating what’s likely to happen next.
Step 4: Model different scenarios
Finally, build a few simple projections.
Think in terms of:
- Best-case and worst-case scenarios
- The potential impact of plan design changes
- The role of clinical strategies and cost containment programs
This doesn’t need to be overly complicated. Even a few structured scenarios can help you understand the range of possible outcomes and prepare accordingly.
When these steps are followed together, forecasting becomes much more manageable.
Instead of relying on assumptions, you’re using real data to guide decisions. And with that clarity, planning ahead for renewal becomes a much more controlled and confident process.
Strategies to reduce uncertainty before renewal
Once you understand what’s driving your pharmacy costs, the next step is taking action to reduce uncertainty before renewal.
This is where having the right strategy in place makes a real difference.
One of the most effective ways to gain control is by managing specialty drug spend proactively.
Specialty medications are often the largest and most unpredictable portion of pharmacy costs. Without a strategy, these expenses can quickly escalate. With the right approach, employers can identify more cost-effective options and better manage how these medications are accessed and delivered.
Another important piece is implementing cost-containment strategies that actively work throughout the year, not just at renewal.
This is where an Rx Optimization Program comes into play.
Instead of simply processing claims, this type of program focuses on continuously identifying savings opportunities, improving access to medications, and creating a more predictable cost structure.
For employers, this brings a level of stability that traditional approaches often lack.
Our Rx Optimization Program includes:
- Free home delivery, making it easier for employees to access their medications while improving adherence
- $0 copays, helping reduce financial barriers and improve the overall member experience
- A risk-free structure with no upfront cost, allowing employers to implement the program without added financial pressure
- Access to a dedicated member advocate, providing personalized support and helping employees navigate their prescriptions
These elements work together to create greater visibility, better predictability, and more control over pharmacy spend.
Instead of waiting for costs to surface at renewal, employers can actively manage them throughout the year.
And that shift, from reactive to proactive, is what ultimately reduces surprises and leads to more confident planning.
What a confident renewal season looks like
After all the analysis, planning, and strategy, renewal season starts to feel very different and clear.
Employers who take a proactive approach walk into renewal conversations prepared, informed, and with a clear understanding of their pharmacy spend. There are fewer surprises because the major cost drivers have already been identified and addressed ahead of time.
Decisions are no longer based on assumptions.
They are data-driven, supported by real insights into utilization trends, high-cost medications, and projected future spend. This makes conversations with partners and vendors more productive and focused.
There is also a stronger sense of control over costs. Rather than reacting to increases, employers are able to explain them, plan for them, and in many cases, reduce their impact through the strategies already in place.
The contrast is clear.
Reactive employers often enter renewal trying to understand what changed and why costs increased. They are working against the clock, reviewing limited information, and making decisions under pressure.
Proactive employers approach renewal differently. They already know what’s driving their costs. They’ve explored their options. They’ve built a strategy that aligns with their goals.
Renewal becomes less about reacting to numbers and more about confirming a plan that’s already in motion.
That shift doesn’t eliminate challenges, but it changes the experience entirely.
Instead of feeling caught off guard, employers move forward with confidence, knowing they’ve done the work to prepare.
From guessing to planning
For many employers, pharmacy costs have always felt like something you react to rather than something you can control.
That approach is starting to change.
Pharmacy costs don’t have to be unpredictable. With better visibility, the right data, and a more structured strategy, forecasting becomes a practical and valuable part of planning, not just a last-minute exercise.
This is where a mindset shift happens.
Forecasting is not just about estimating numbers. It becomes a way to anticipate trends, prepare for changes, and make more confident decisions before renewal even begins.
Employers who take this approach are no longer relying on guesswork. They are building a clearer understanding of their pharmacy spend and using that insight to guide their strategy throughout the year.
The tools and partners you choose play an important role in making this possible.
Working with solutions that provide transparency, real-time insights, and ongoing support allows employers to stay informed and make adjustments as needed, rather than waiting for costs to surface later.
Employers that have visibility into their pharmacy data aren’t just reacting to costs, they’re planning for them.
And that shift is what makes long-term cost control more achievable.
Key Takeaways
- Pharmacy costs can be forecasted with the right data and approach
- Many employers struggle with limited visibility, delayed reporting, and hidden costs
- Reviewing key data before renewal helps shift from reactive to proactive planning
- Waiting until renewal to evaluate pharmacy spend limits options and increases pressure
- A structured approach to forecasting makes planning more accurate and manageable
- Rx Optimization Programs help improve visibility, predictability, and cost control Employers who plan ahead enter renewal more confident, informed, and in control
